Sanja Đačić

26.8k total citations · 4 hit papers
171 papers, 9.5k citations indexed

About

Sanja Đačić is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Sanja Đačić has authored 171 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Pulmonary and Respiratory Medicine, 71 papers in Oncology and 40 papers in Cancer Research. Recurrent topics in Sanja Đačić's work include Lung Cancer Treatments and Mutations (68 papers), Cancer Genomics and Diagnostics (32 papers) and Lung Cancer Diagnosis and Treatment (32 papers). Sanja Đačić is often cited by papers focused on Lung Cancer Treatments and Mutations (68 papers), Cancer Genomics and Diagnostics (32 papers) and Lung Cancer Diagnosis and Treatment (32 papers). Sanja Đačić collaborates with scholars based in United States, Canada and United Kingdom. Sanja Đačić's co-authors include Mary Beth Beasley, Samuel A. Yousem, Philip T. Cagle, Marina N. Nikiforova, Kathleen Cieply, Neal I. Lindeman, Raja R. Seethala, Erik Thunnissen, Marc Ladanyi and Jeremy A. Squire and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sanja Đačić

169 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

2013 967 citations Neal I. Lindeman, Mary Beth Beasley et al. Journal of Thoracic Oncology profile →
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015

2021 752 citations Andrew G. Nicholson, Ming‐Sound Tsao et al. Journal of Thoracic Oncology profile →
Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population

2009 526 citations Scott J. Rodig, Mari Mino–Kenudson et al. Clinical Cancer Research profile →
The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification

2022 95 citations Sanja Đačić, Françoise Galateau-Sallé et al. Journal of Thoracic Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanja Đačić United States	51	6.1k	4.1k	2.3k	2.2k	1.5k	171	9.5k
Koji Tsuta Japan	54	5.4k 0.9×	4.5k 1.1×	3.2k 1.4×	1.9k 0.9×	988 0.7×	301	9.9k
Robert T. Heelan United States	38	7.2k 1.2×	5.5k 1.3×	2.5k 1.1×	1.5k 0.7×	840 0.6×	78	9.7k
Axel Le Cesne France	62	9.7k 1.6×	7.1k 1.7×	1.5k 0.6×	902 0.4×	2.2k 1.5×	265	14.6k
Antonio Llombart‐Bosch Spain	43	3.4k 0.6×	1.8k 0.4×	1.8k 0.8×	1.0k 0.5×	1.1k 0.7×	294	6.7k
Fernando López‐Ríos Spain	44	2.7k 0.5×	3.2k 0.8×	2.1k 0.9×	1.8k 0.8×	812 0.5×	177	6.4k
Shumei Kato United States	38	2.4k 0.4×	4.5k 1.1×	2.2k 0.9×	2.6k 1.2×	769 0.5×	174	7.5k
Sylvie Lantuéjoul France	45	3.7k 0.6×	3.2k 0.8×	2.1k 0.9×	1.2k 0.5×	662 0.4×	154	6.9k
Gabriella Fontanini Italy	56	4.7k 0.8×	7.2k 1.8×	5.3k 2.3×	2.7k 1.2×	1.3k 0.8×	320	13.4k
Giancarlo Troncone Italy	53	2.5k 0.4×	3.3k 0.8×	4.0k 1.7×	3.0k 1.4×	1.3k 0.9×	356	9.7k
Marie Wislez France	47	4.1k 0.7×	4.5k 1.1×	2.0k 0.8×	958 0.4×	741 0.5×	284	8.1k

Countries citing papers authored by Sanja Đačić

Since Specialization

Citations

This map shows the geographic impact of Sanja Đačić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanja Đačić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanja Đačić more than expected).

Fields of papers citing papers by Sanja Đačić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanja Đačić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanja Đačić. The network helps show where Sanja Đačić may publish in the future.

Co-authorship network of co-authors of Sanja Đačić

This figure shows the co-authorship network connecting the top 25 collaborators of Sanja Đačić. A scholar is included among the top collaborators of Sanja Đačić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanja Đačić. Sanja Đačić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Yuan, Jian‐Min, Thomas W. Kensler, Sanja Đačić, et al.. (2025). Randomized Phase II Clinical Trial of Sulforaphane in Former Smokers at High Risk for Lung Cancer. Cancer Prevention Research. 18(6). 335–345. 3 indexed citations

2.

Klebe, Sonja, Meagan Judge, Luka Brčić, et al.. (2023). Mesothelioma in the pleura, pericardium and peritoneum: Recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 84(4). 633–645. 4 indexed citations

3.

Goldman, Jonathan W., Lynette M. Sholl, Sanja Đačić, et al.. (2023). Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer. Frontiers in Oncology. 13. 1178313–1178313. 3 indexed citations

4.

Silva, Suzane Ramos da, Enguo Ju, Wen Meng, et al.. (2021). Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019. The Journal of Infectious Diseases. 223(11). 1842–1854. 29 indexed citations

5.

Nicholson, Andrew G., Ming‐Sound Tsao, Mary Beth Beasley, et al.. (2021). The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. Journal of Thoracic Oncology. 17(3). 362–387. 752 indexed citations breakdown →

6.

Naso, Julia, Adrian Levine, Hossein Farahani, et al.. (2021). Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations. Modern Pathology. 34(11). 2028–2035. 15 indexed citations

7.

Stabile, Laura P., Vinod Kumar, Eric H.‐B. Huang, et al.. (2020). Syngeneic tobacco carcinogen–induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden. JCI Insight. 6(3). 15 indexed citations

8.

Foxwell, Tyler, Kathleen Cieply, Sarah Navina, et al.. (2012). HER2Amplification in Gastroesophageal Adenocarcinoma. American Journal of Clinical Pathology. 137(4). 583–594. 29 indexed citations

9.

Chiosea, Simion I., Sanja Đačić, Marina N. Nikiforova, & Raja R. Seethala. (2012). Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: Clinical Implications. The Laryngoscope. 122(8). 1690–1694. 44 indexed citations

10.

Stabile, Laura P., Sanja Đačić, Stephanie R. Land, et al.. (2010). Combined Analysis of Estrogen Receptor β-1 and Progesterone Receptor Expression Identifies Lung Cancer Patients with Poor Outcome. Clinical Cancer Research. 17(1). 154–164. 129 indexed citations

11.

Krasinskas, Alyssa M., David L. Bartlett, Kathleen Cieply, & Sanja Đačić. (2010). CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival. Modern Pathology. 23(4). 531–538. 83 indexed citations

12.

Rodig, Scott J., Mari Mino–Kenudson, Sanja Đačić, et al.. (2009). Unique Clinicopathologic Features Characterize ALK -Rearranged Lung Adenocarcinoma in the Western Population. Clinical Cancer Research. 15(16). 5216–5223. 526 indexed citations breakdown →

13.

Stabile, Laura P., Mary E. Rothstein, Phouthone Keohavong, et al.. (2008). Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis. Molecular Cancer Therapeutics. 7(7). 1913–1922. 35 indexed citations

14.

Đačić, Sanja. (2008). EGFR Assays in Lung Cancer. Advances in Anatomic Pathology. 15(4). 241–247. 36 indexed citations

15.

Moser, A. James, Kenneth K Lee, Herbert J. Zeh, et al.. (2008). Array comparative genomic hybridization analysis of solid pseudopapillary neoplasms of the pancreas. Modern Pathology. 21(5). 559–564. 14 indexed citations

16.

Yue, Wen, Sanja Đačić, Quanhong Sun, et al.. (2007). Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation. Clinical Cancer Research. 13(15). 4336–4344. 72 indexed citations

17.

Đačić, Sanja, et al.. (2007). Microsatellite Instability Is Uncommon in Lymphoepithelioma-like Carcinoma of the Lung. American Journal of Clinical Pathology. 127(2). 282–286. 9 indexed citations

18.

Đačić, Sanja, et al.. (2007). Microsatellite Instability Is Uncommon in Lymphoepithelioma-like Carcinoma of the Lung. American Journal of Clinical Pathology. 127(2). 282–286. 1 indexed citations

19.

Weigel, Tracey L., et al.. (2001). Postoperative fluorescence bronchoscopic surveillance in non–small cell lung cancer patients. The Annals of Thoracic Surgery. 71(3). 967–970. 34 indexed citations

20.

Dodig, Milan, Ivo Rotkvić, Željko Grabarević, et al.. (1993). Pentagastrin Cytoprotection in Ethanol‐Induced Gastric Mucosal Lesions in Rats. Journal of Veterinary Medicine Series A. 40(1-10). 509–515. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact